Filing Details
- Accession Number:
- 0001127602-17-002766
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-30 10:53:43
- Reporting Period:
- 2017-01-26
- Filing Date:
- 2017-01-30
- Accepted Time:
- 2017-01-30 10:53:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 794172 | Meridian Bioscience Inc | VIVO | In Vitro & In Vivo Diagnostic Substances (2835) | 310888197 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1224664 | Lawrence Baldini | 3471 River Hills Drive Cincinnati OH 45244 | Evp, Pres Global Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-01-26 | 4,000 | $12.70 | 106,934 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
